<DOC>
	<DOCNO>NCT02121782</DOCNO>
	<brief_summary>The purpose study determine whether GC3110A ( QIV ) effective compare GC Flu Pre-filled Syringe Inj . ( marketed TIV ) single intramuscular administration Korean healthy adult . The comparator , GC Flu pre-filled syringe inj . trivalent influenza vaccine ( TIV ) include virus represent 3 influenza strain ( one A/HIN1 , one A/H3N2 , one B ) . However , two antigenically distinct lineage influenza B ( Victoria Yamagata ) co-circulate annually United States . Predicting lineage influenza B predominate season challenge , cross-protection immunization lineage expect low . One propose alternative produce quadrivalent influenza vaccine ( QIV ) include influenza B virus two circulating lineage . GC3110A new quadrivalent influenza vaccine ( QIV ) , contain 4 vaccine component WHO recommend use 2013-14 influenza season ( northern hemisphere winter ) include two influenza B virus . GC3110A expect show additional public health benefit compare traditional TIV .</brief_summary>
	<brief_title>A Phase I/IIa Study GC3110A ( Quadrivalent Influenza Vaccine )</brief_title>
	<detailed_description>This study first human trial GC3110A design adaptive Phase I/IIa ensure participant protection . Part A open-label single arm study 9 healthy volunteer . Data Safety Monitoring Board ( DSMB ) review solicited/unsolicited adverse event conditionally toxicity Grade 3 4 report 7 day vaccination . Part B randomize ( 2:1 ) , double-blind , active control study total 75 volunteer participate part . Adverse event assessment do accord 'Toxicity Grading Scale Healthy Adult Adolescent Volunteers Enrolled Preventive Vaccine Clinical Trials ' .</detailed_description>
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Given write informed consent Healthy Korean adult ( age : 19 65 ) Korean adult agree 21 day follow vaccination good compliance study procedure Those able comply requirement study Inability written/verbal communication Subjects participate interventional study within 30 day Alcohol drug abuse within 6 month Heavy drinker subject agree stop drinking 3 day vaccination 3 day vaccination Who get treatment psychotropic drug narcotic analgesic drug within 6 month enrollment Hypersensitivity drug active ingredient Disorders immune function History GuillainBarré syndrome Disease/medications likely cause severe bleed Active infection experience fever ( &gt; 38.0 ℃ ) within 72 hour follow vaccination Oral temperature &gt; 38.0 ℃ vaccination day Erythema , tattoo , injury shoulder ( vaccination site ) Hypersensitivity egg , chicken , vaccine component , Neomycin , Gentamicin Influenza vaccination within 6months Any vaccination within 30 day Concomitant medications/therapy immunosuppressant immune modify drug , systemic corticosteroid , immunoglobulin , blood blood derive product , anticancer chemotherapy radiation therapy within3 month Pregnant breastfeed woman Clinically significant underlying disease medical history investigator 's discretion</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>QIV</keyword>
	<keyword>Quadrivalent Influenza Vaccine</keyword>
	<keyword>Influenza vaccine</keyword>
	<keyword>Vaccination</keyword>
</DOC>